Efficient T-cell engineering is crucial for the success of CAR T-cell therapy research, but it requires multiple labor-intensive steps, including T-cell isolation, activation, and transduction.

This review article highlights the transformative potential of in vivo CAR T cell therapy in addressing the limitations of ...

The firm, founded on research from the University of Pennsylvania, says it can manufacture the cells in just three days using cell-derived nanoparticles.

Renier Brentjens, MD, PhD, one of the pioneers in the development of chimeric antigen receptor (CAR) T-cell therapy, is poised to see the technology take its next big leap, with researchers testing ...

From Bambino Gesù Children's Hospital in Rome comes a report that a third-generation CAR T cell therapy targeting GD2, ...

Researchers at the Cancer Center at Illinois have released new findings on an innovative mRNA cancer vaccine platform.